Usha Chakravarthy's guest appearances

Usha Chakravarthy

The Retina Channel Podcast

David Brown

Jason Hsu

Pravin Dugel

David Almeida

Mark Gillies

Richard Rosen

Mark Humayun

Rajeev Muni

Jennifer Sun

Cecilia Lee

Matthew Schrag

Camiel Boon

Sean Adrean

Charles Wykoff

Rob Devenyi

OwlTail

Dr. Chakravarthy from Belfast, UK discusses a secondary analysis of the IVAN Trial to compare effects of intravitreal anti-VEGF therapy on serum VEGF levels with possible trends in system adverse events in the context of wet AMD. Full reference: Chris A.Rogers, Lauren J.Scott, Barnaby C.Reeves, Susan Downes, Andrew J.Lotery, Andrew D.Dick, Usha Chakravarthy for IVAN trial investigators, Serum Vascular Endothelial Growth Factor Levels in the IVAN Trial; Relationships with Drug, Dosing, and Systemic Serious Adverse Events, Ophthalmology Retina, Feb. 2018 http://dx.doi.org/10.1016/j.oret.2017.05.015

Dr. Chakravarthy from Belfast, UK discusses a secondary analysis of the IVAN Trial to compare effects of intravitreal anti-VEGF therapy on serum VEGF levels with possible trends in system adverse events in the context of wet AMD. Full reference: Chris A.Rogers, Lauren J.Scott, Barnaby C.Reeves, Susan Downes, Andrew J.Lotery, Andrew D.Dick, Usha Chakravarthy for IVAN trial investigators, Serum Vascular Endothelial Growth Factor Levels in the IVAN Trial; Relationships with Drug, Dosing, and Systemic Serious Adverse Events, Ophthalmology Retina, Feb. 2018 <a href="http://dx.doi.org/10.1016/j.oret.2017.05.015" rel="nofollow" target="_blank">http://dx.doi.org/10.1016/j.oret.2017.05.015</a>

E15-Serum VEGF Levels in the IVAN Trial- Dr. Usha Chakravarthy